Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Share Price

Price 3.4435p on 05-05-2025 at 18:15:11
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell IMM Shares
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 2,526.00 at 3.4435p
Day's Volume: 0
Last Close: 3.4435p
Open: 0.00p
ISIN: GB0033711010
Day's Range 0.00p - 0.00p
52wk Range: 0.85p - 7.26p
Market Capitalisation: £14m
VWAP: 0.00p
Shares in Issue: 416m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Immupharma (IMM) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 2,526 3.4435p Ordinary
 16:26:28 - 02-May-25
Sell* 26,973 3.4435p Ordinary
 16:21:22 - 02-May-25
Sell* 49,985 3.3449p Ordinary
 16:10:17 - 02-May-25
Buy* 272 3.3458p Ordinary
 15:59:26 - 02-May-25
Buy* 20,000 3.33p Ordinary
 15:57:41 - 02-May-25
Buy* 298 3.3458p Ordinary
 15:57:11 - 02-May-25
Buy* 68,923 3.3298p Ordinary
 15:49:04 - 02-May-25
Buy* 30,000 3.33p Ordinary
 15:39:50 - 02-May-25
Buy* 50,000 3.3398p Ordinary
 15:32:59 - 02-May-25
Sell* 30,000 3.21556p Ordinary
 15:27:06 - 02-May-25
See more Immupharma trades

Immupharma (IMM) Share Price History

Time period:
to
Date Open High Low Close Volume
5th May 2025 (Mon) 3.4435 3.4435 3.4435 3.4435 0
2nd May 2025 (Fri) 3.32 3.38 3.16 3.44 3,282,333
1st May 2025 (Thu) 4.00 4.00 3.20 3.505 8,786,903
30th Apr 2025 (Wed) 2.54 4.30 2.54 3.70 16,220,717
29th Apr 2025 (Tue) 2.58 2.62 2.48 2.52 1,834,911
28th Apr 2025 (Mon) 2.50 2.64 2.30 2.64 2,141,084
25th Apr 2025 (Fri) 2.50 2.50 2.40 2.425 1,416,059
24th Apr 2025 (Thu) 2.30 2.48 2.30 2.60 827,781
23rd Apr 2025 (Wed) 2.49 2.78 2.45 2.60 3,720,133
22nd Apr 2025 (Tue) 2.45 2.55 2.40 2.55 2,930,772
21st Apr 2025 (Mon) 2.575 2.575 2.575 2.575 0
18th Apr 2025 (Fri) 2.575 2.575 2.575 2.575 0
17th Apr 2025 (Thu) 2.40 2.50 2.40 2.575 1,265,360
16th Apr 2025 (Wed) 2.40 2.44 2.40 2.55 1,265,654
15th Apr 2025 (Tue) 2.30 2.42 2.30 2.60 2,197,658
14th Apr 2025 (Mon) 2.40 2.40 2.40 2.44 692,292
11th Apr 2025 (Fri) 2.50 2.58 2.40 2.57 778,493
10th Apr 2025 (Thu) 2.45 2.78 2.32 2.56 504,310
9th Apr 2025 (Wed) 2.14 2.35 2.14 2.15 1,073,208
8th Apr 2025 (Tue) 2.55 2.55 2.30 2.50 1,143,919
7th Apr 2025 (Mon) 2.40 2.61 2.26 2.61 4,087,716
See more Immupharma price history

Immupharma (IMM) Regulatory News

Date Source Headline
1st Apr 2025 7:00 am RNS Warrant Extension, Debt Conversion & Equity Issue
1st Apr 2025 7:00 am RNS Extension of Warrants in Incanthera to 30 Sep 2025
14th Mar 2025 7:00 am RNS-R IMM attending Bio-Europe Spring 17-19 March,Milan
13th Mar 2025 7:00 am RNS ImmuPharma proves unique Mechanism of Action-P140
21st Feb 2025 11:36 am RNS Holding(s) in Company
13th Feb 2025 7:00 am RNS £2.91m fundraising; related party transactions
28th Jan 2025 12:57 pm RNS Response to Share Price Movement
9th Jan 2025 7:00 am RNS Breakthrough Findings into Autoimmune Diseases
23rd Dec 2024 7:00 am RNS Change of Auditor
10th Dec 2024 2:36 pm RNS Holding(s) in Company
See more Immupharma regulatory news

Immupharma (IMM) Share News

ImmuPharma celebrates "significant milestone" for P140 platform

13th Mar 2025 16:27

(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform. Read More

AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses

13th Mar 2025 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

IN BRIEF: ImmuPharma notes share price surge after novel findings

28th Jan 2025 14:28

ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multiplied nearly five times higher in the last month to 6.03p per share, from 1.21p. The stock surged 94% higher in a single day in early January, to 2.33p, after ImmuPharma reported breakthrough findings in its preclinical research programme focused on P140 and the pathogenesis of autoimmune diseases. Read More

IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings

9th Jan 2025 11:21

ImmuPharma PLC - London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 and the pathogenesis of autoimmune diseases has yielded data that provides novel insights into autoimmune mechanisms. P140, the firms lead programme, is a unique non-immunosuppressive peptide for the treatment of systemic lupus erythematosus and chronic idiopathic demyelinating polyneuropathy. Adds that the findings, which were discovered by its R&D subsidiary ImmuPharma Biotech, pave the way for better diagnostics, identifying patients most likely to respond to P140 therapy and improved patient monitoring. Says the research marks a "significant step towards personalised medicine in SLE and other autoimmune diseases." Details of the data findings are not being released at this time since they form part of the ongoing expansion of the firms intellectual property portfolio. Read More

AIM WINNERS & LOSERS: ImmuPharma jumps; Impax Asset hit by outflows

9th Jan 2025 09:53

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

See more Immupharma news
FTSE 100 Latest
Value8,596.35
Change99.55

Login to your account

Forgot Password?

Not Registered